Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
CSL (AU:CSL)
ASX:CSL
CSL (CSL) Share Price & Analysis
5 Followers
CSL Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$251.41 - AU$312.57
Previous CloseAU$310.29
Volume22.29K
Average Volume (3M)676.71K
Market Cap
AU$149.67B
Enterprise ValueAU$148.49B
Total Cash (Recent Filing)$10.44B
Total Debt (Recent Filing)$9.66B
Price to Earnings (P/E)47.7
Beta0.67
Next Earnings
Aug 16, 2023EPS Estimate
AU$2.6Last Dividend Ex-Date
Mar 09, 2023Dividend Yield
1.12 (0.37%)Share Statistics
EPS (TTM)6.51
Shares Outstanding482,369,261
10 Day Avg. Volume827,868
30 Day Avg. Volume676,714
Standard Deviation0.06
R-Squared0.14
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit26.22
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$344.79Price Target Upside12.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
CSL FAQ
What was CSL’s price range in the past 12 months?
CSL lowest share price was AU$251.41 and its highest was AU$312.57 in the past 12 months.
What is CSL’s market cap?
Currently, no data Available
When is CSL’s upcoming earnings report date?
CSL’s upcoming earnings report date is Aug 16, 2023 which is in 74 days.
How were CSL’s earnings last quarter?
CSL released its earnings results on Feb 13, 2023. The company reported AU$5.716 earnings per share for the quarter, beating the consensus estimate of AU$5.299 by AU$0.417.
Is CSL overvalued?
According to Wall Street analysts CSL’s price is currently Undervalued.
Does CSL pay dividends?
CSL pays a Semiannually dividend of AU$1.53 which represents an annual dividend yield of 1.18%. See more information on CSL dividends here
What is CSL’s EPS estimate?
CSL’s EPS estimate is AU$2.6.
How many shares outstanding does CSL have?
CSL has 482,369,260 shares outstanding.
What happened to CSL’s price movement after its last earnings report?
CSL reported an EPS of AU$5.716 in its last earnings report, beating expectations of AU$5.299. Following the earnings report the stock price went up 0.898%.
Which hedge fund is a major shareholder of CSL?
Currently, no hedge funds are holding shares in AU:CSL
---
CSL Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$344.79 (12.10% Upside)
AU$344.79 (12.10% Upside)
Blogger Sentiment
Bullish
AU:CSL Sentiment 95%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.32%
12-Months-Change
Fundamentals
Return on Equity
14.37%
Trailing 12-Months
Asset Growth
51.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.
---
Top 5 ETFs holding CSL
iShares MSCI Australia ETF
$185.36M
iShares Global Healthcare ETF
$55.10M
UBS (Irl) ETF Plc - MSCI Australia UCITS ETF
$42.57M
UBS (Irl) ETF Plc - MSCI Australia UCITS ETF (hedged to GBP) A-acc
$42.57M
UBS (Irl) ETF plc - MSCI Australia UCITS ETF
$42.57M
Up to five ETFs with an Outperform Smart Score that hold CSL. The ETFs are listed according to market value of CSL within the ETF
---
---